{"lc": 1, "type": "constructor", "id": ["langchain", "schema", "document", "Document"], "kwargs": {"metadata": {"source": "/home/guanzhideng145/research/ip_portal/patent_kg/patents/747-US20210179749A1(Done on website).pdf"}, "page_content": "prises a pharmaceutically active ingredient . Preferably , the\n\nFormula ( IIb )\n\nhydrophobic material comprises an antimicrobial com\n\nR2\n\nRi\n\npound .\n\nR6\n\nR3\n\n[ 0024 ]\n\nIn a preferred embodiment , the hydrophobic mate\n\nrial is an essential oil . For example , the hydrophobic mate\n\nRS\n\nR4\n\nrial comprises a compound selected from a group consisting\n\nof carvacrol , thymol , p - cymene , and limonene .\n\n[ 0016 ]\n\nin which :\n\n[ 0017 ] R , and R2 are independently selected from the\n\n[ 0025 ]\n\nIn an embodiment , the hydrophobic material dis\n\ngroup consisting of ( i ) a linear or branched alkyl\n\nrupts bonding in the one or more monomeric units .\n\ngroup , optionally comprising a heteroatom ; and ( ii )\n\na cycloalkyl group , optionally comprising a heteroa\n\n( 0026 ]\n\nIn another embodiment , the composition is a self\n\nhealing , sustained release antimicrobial .\n\ntom ;\n\n[ 0018 ] R3 , R4 , R , and Rg are independently selected\n\nfrom the group consisting of ( i ) a linear or branched\n\n[ 0027 ]\n\nPreferably , the composition has an elastic modulus\n\nalkyl group , optionally comprising a heteroatom , ( ii )\n\nof at least 50 MPa at 25 \u00b0 C. and of less than 5 MPa at 100 \u00b0\n\na heteroatom , and ( iii ) a hydrogen atom ; and\n\nC.\n\n[ 0019 ]\n\nthe dotted line denotes no double bond or one\n\ndouble bond .\n\n[ 0020 ]\n\nIn a particular embodiment , R has a structure of\n\n[ 0028 ] A second aspect of the present invention relates to\n\nFormula ( Ilb ) with R1 , R2 , Rz and R4 being a linear or\n\na method of preparing a composition , the method compris\n\nbranched alkyl group , and R , and Ro being a hydrogen atom .\n\ning the steps of ( a ) providing one or more monomeric units ,\n\n[ 0021 ]\n\nIn a further embodiment , the monomeric unit has a\n\nthe monomeric unit having a structure of Formula ( I ) :\n\nstructure of Formula ( III ) :\n\nFormula ( III )\n\nHN\n\nHN\n\nZI\n\nNH\n\n( CH2 )\n\nIZ\n\n( H2C ) :\n\nO.\n\nNH\n\nC6H13\n\nC6H13\n\nFormula ( 1 )\n\nHN\n\n( CH2 ) ,\n\n( CH2 ) ,\n\nNH\n\nJun. 17, 2021\n\nUS 2021/0179749 Al", "type": "Document"}}